Phase II Efficacy Study of AZD6244 in Colorectal Cancer
The purpose of the study is to assess if there is benefit when using AZD6244 in the treatment if metastatic colorectal cancer in comparison with another treatment called capecitabine. This study will also assess how safe and well tolerated AZD6244 is.
Metastatic Colorectal Cancer
DRUG: AZD6244|DRUG: Capecitabine
Progression event count, assessed after each visit
safety and tolerability, assessed at each visit
The purpose of the study is to assess if there is benefit when using AZD6244 in the treatment if metastatic colorectal cancer in comparison with another treatment called capecitabine. This study will also assess how safe and well tolerated AZD6244 is.